Diadem: Funding, Investors & Team (Sep 2026)
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
Diadem has raised $11.0M across 1 funding round on record, the most recent an undisclosed round of $11.0M announced in Mar 2022.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Diadem Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Diadem Funding Rounds
Diadem Founders and Leadership Team
No contact details are on record for this team yet.
Diadem Funding Compared to Other Health Care Startups
Diadem's latest round of $11.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Diadem in Health Care and Brescia
Companies Similar to Diadem
Niino is a digital healthcare logistics platform provide easy, rapid, and transparent access to non-urgent…
Salute360 is a digital health company committed to transforming the way patients and healthcare professionals…
Rosso is a startup in Italy focused on addressing the blood shortage crisis by connecting various…
Pharma Green Holding is a company that aims to create a unified and advanced pharmacy network that delivers…
A Start Up founded in December 2016 and committed to the discovery and development of orphan drugs for…
Antonio D'Angelo and Andrea Cazzulani discovered that a highly effective medication was struggling to become…
Approxima is a new MedTech startup in the early stages of developing a method for replacing the tricuspid…
Restorative Neurotechnologies is a pioneer in non-invasive neuromodulation for the rehabilitation of…
Dentistry nutraceuticals
We apply IT to Bionics in order to Turn disabilities into New Possibilities
Soundsafe Care is a medical startup company that disrupts traditional surgical practices by combining…
Diadem Funding FAQs
What does Diadem do?
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
How much funding has Diadem raised?
Diadem has raised $11.0M across 1 round on record. The most recent is an undisclosed round of $11.0M announced in Mar 2022.
When did Diadem last raise funding?
Diadem's most recent funding round on record is an undisclosed round of $11.0M, announced in Mar 2022.
Who is the CEO of Diadem?
Paul Kinnon is listed as CEO at Diadem.
Where is Diadem headquartered?
Diadem is based in Brescia, Lombardia, Italy.
How does Diadem's funding compare to other Health Care startups?
Diadem's latest round of $11.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Diadem Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Diadem is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.